Michael N. VanSaun, Ph.D.
- Research Assistant Professor
The overall goal of Dr. VanSaun research is to identify novel therapeutics to prevent and/or reduce the mortality from pancreatic cancer. His lab is focused on understanding obesity as a risk factor and the effect of adipokines on cancer progression. Dr. VanSaun has generated genetically engineered mouse (GEM) models and established a bank of pancreatic patient-derived xenograft models to study disease progression as well as to test targeted therapeutics in translationally applicable models.